NCT03349632.

Methods	RCT, parallel‐group, cross‐over design
Participants	Inclusion criteria: aged 18 years and older; successfully wears daily disposable spherical SCL in both eyes for a minimum of 5 days per week, 8 hours per day, at least the past 3 months; BCVA of 20/25 Snellen or better in each eye Exclusion criteria: any eye condition, surgery, disease, or use of medication that contraindicates contact lens wear; routinely sleeps in habitual contact lenses; currently wears any study SCL
Interventions	Verofilcon A material: silicone hydrogel replacement frequency: daily Senofilcon A material: silicone hydrogel replacement frequency: daily Stenfilcon A material: silicone hydrogel replacement frequency: daily Etafilcon A material: hydrogel (incorrectly described as silicone hydrogel on ClinicalTrials.gov) replacement frequency: daily
Outcomes	Primary outcome: overall quality of binocular vision (10‐point scale; 1 = poor to 10 = excellent) Secondary outcomes: not specified
Notes	Sponsorship source: Alcon Research Author's name: not reported Institution: Alcon Research Comments: whether the analysis accounted for cross‐over design was unclear